Phase 3 Oesophageal Cancer Trial, Recruiting NCT04821843 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Phase 3 Oesophageal Cancer Trial, Recruiting

NCT04821843
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with cancer of the esophagus (food pipe) or where the esophagus meets the stomach
  • Your cancer has been confirmed by a tissue sample (biopsy) as a specific type (squamous cell carcinoma or adenocarcinoma), at a stage between I and IVa
  • Your primary cancer treatment was carried out at the Cancer Hospital, Chinese Academy of Medical Sciences
  • You are generally active and able to care for yourself, with only mild limitations on physical activity (confirm with trial site)
  • Your doctors expect you to live for at least 3 more months
  • Your blood counts, kidney function, liver function, and blood clotting levels are all within acceptable ranges (confirm with trial site for specific values)
  • You are willing and able to give informed consent to take part

Who may not be able to join:

  • Your cancer has spread to distant parts of the body such as the liver, lungs, bones, or brain
  • You have been diagnosed with another cancer in the past 5 years (except for certain early-stage skin cancers or cervical pre-cancer)
  • You currently have an active infection such as active tuberculosis or hepatitis
  • You have had a heart attack in the last 6 months, or have a history of certain irregular heart rhythms
  • You have an uncontrolled illness, including serious heart problems, unstable chest pain, uncontrolled infections, or a significant mental health condition
  • You have had an allergic reaction to paclitaxel, albumin, or cisplatin (medicines used in this trial)
  • You are currently in another clinical trial, or have been in one within the last 4 weeks
  • You are pregnant or breastfeeding
  • You do not have accessible medical records

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +861013311583220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 January 2002
Est. completion
31 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov